SCHEMBL13101050

SCHEMBL13101050

CC(C)C(=O)CNC(=O)c1ccnnc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PREP P48147 1/20 0.45
HCAR2 Q8TDS4 1/20 0.44
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
THRB P10828 1/20 0.41
KMT2A Q03164 4/20 0.38
MEN1 O00255 2/20 0.38
TSHR P16473 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PIK3CD O00329 1/20 0.37
ACACB O00763 2/20 0.36
GPR139 Q6DWJ6 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
PTGS2 P35354 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13101448 0.82 L3MBTL1 (0.54) KMT2ATSHRL3MBTL1LMNAMAOA
SCHEMBL13113096 0.82 HCAR2 (0.48) PREPHCAR2HDAC3HDAC1THRB
SCHEMBL12974089 0.80 THRB (0.67) HDAC1THRBKMT2AMEN1TSHR
SCHEMBL13197233 0.79 KDM4E (0.48) KMT2AMEN1GPR139NPC1LMNA
SCHEMBL22322593 0.79 KDM4E (0.51) PREPHCAR2HDAC3HDAC1THRB
SCHEMBL15738287 0.78 SMN1; SMN2 (0.54) HCAR2HDAC3HDAC1KMT2ATSHR
SCHEMBL21408751 0.76 PREP (0.46) PREPHCAR2HDAC3HDAC1THRB
SCHEMBL13197234 0.76 KMT2A (0.48) HDAC3HDAC1KMT2ATSHRNPC1
SCHEMBL12508393 0.75 RAB9A (0.53) GPR139NPC1HTT
SCHEMBL11007742 0.75 GPR139 (0.59) KMT2AGPR139NPC1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530646-B2 Oxazolidinone derivative having 7-membered hetero ring RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2013-09-10 US disclosed
US-20100256355-A1 OXAZOLIDINONE DERIVATIVE HAVING 7-MEMBERED HETERO RING Research Foundation ITSUU Laboratory and Shionogi & Co., Ltd. 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256355-A1 OXAZOLIDINONE DERIVATIVE HAVING 7-MEMBERED HETERO RING NR0B2, NR0B1, NR2C2 PREP 4694/4885HCAR2 746/4885HDAC3 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.